Cellebrite DI Ltd. (NASDAQ:CLBT) Receives Consensus Recommendation of "Buy" from Brokerages

Key Points

• Cellebrite DI Ltd. has received a consensus rating of "Buy" from five research firms, with an average price target of $22.40 among analysts.
• The company recently reported an earnings per share (EPS) of $0.12 for the last quarter, surpassing estimates and achieving an 18.4% year-over-year revenue growth.
• In recent months, several institutional investors have increased their stakes in Cellebrite DI, indicating growing confidence in the company's prospects.

Cellebrite DI Ltd. (NASDAQ:CLBT - Get Free Report) has been given an average rating of "Buy" by the five brokerages that are presently covering the firm, MarketBeat Ratings reports. Five research analysts have rated the stock with a buy rating. The average 12-month target price among brokers that have covered the stock in the last year is $22.40.

CLBT has been the topic of several recent analyst reports. Lake Street Capital dropped their price objective on Cellebrite DI from $24.00 to $22.00 and set a "buy" rating on the stock in a research report on Friday, August 15th. Wall Street Zen upgraded Cellebrite DI from a "hold" rating to a "buy" rating in a research note on Saturday, August 16th. Needham & Company LLC reduced their target price on shares of Cellebrite DI from $24.00 to $18.00 and set a "buy" rating for the company in a report on Thursday, August 14th. Finally, JPMorgan Chase & Co. decreased their target price on Cellebrite DI from $29.00 to $25.00 and set an "overweight" rating on the stock in a report on Monday, May 12th.

Institutional Trading of Cellebrite DI

Institutional investors and hedge funds have recently modified their holdings of the company. Signaturefd LLC raised its holdings in Cellebrite DI by 68.3% during the second quarter. Signaturefd LLC now owns 2,019 shares of the company's stock valued at $32,000 after acquiring an additional 819 shares during the period. Assetmark Inc. bought a new position in shares of Cellebrite DI during the first quarter worth $33,000. PNC Financial Services Group Inc. increased its holdings in Cellebrite DI by 1,998.0% in the 2nd quarter. PNC Financial Services Group Inc. now owns 2,098 shares of the company's stock valued at $34,000 after acquiring an additional 1,998 shares during the last quarter. Catalyst Capital Advisors LLC purchased a new stake in Cellebrite DI in the 1st quarter worth $51,000. Finally, Virtus Advisers LLC purchased a new stake in Cellebrite DI in the 1st quarter worth $63,000. 45.88% of the stock is currently owned by institutional investors.

Cellebrite DI Price Performance

CLBT stock traded up $0.20 on Wednesday, reaching $16.11. 1,663,790 shares of the company traded hands, compared to its average volume of 2,291,514. The firm has a fifty day simple moving average of $14.95 and a 200-day simple moving average of $17.41. The company has a market cap of $3.86 billion, a P/E ratio of -21.20, a price-to-earnings-growth ratio of 3.19 and a beta of 1.27. Cellebrite DI has a one year low of $13.10 and a one year high of $26.30.

Cellebrite DI (NASDAQ:CLBT - Get Free Report) last announced its quarterly earnings results on Thursday, August 14th. The company reported $0.12 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.11 by $0.01. Cellebrite DI had a negative net margin of 34.56% and a positive return on equity of 23.92%. The company had revenue of $113.28 million for the quarter, compared to analysts' expectations of $112.33 million. During the same quarter in the previous year, the business posted $0.10 EPS. Cellebrite DI's revenue was up 18.4% compared to the same quarter last year. Cellebrite DI has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. On average, sell-side analysts forecast that Cellebrite DI will post 0.3 EPS for the current year.

About Cellebrite DI

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.